Synapticure, a virtual care company for neurodegenerative diseases, has secured $25 million in Series A funding to scale its services and expand its partnerships with health systems, payers and providers, it announced Tuesday.
Chicago-based Synapticure serves people and their families living with neurodegenerative diseases like Alzheimer’s, Parkinson’s and ALS. Its virtual platform provides access to neurologists, treatments, trials, care coordination services and behavioral health support. It works with health plans and providers and operates in all 50 states.
The Series A round was led by B Capital and included participation from CommonSpirit Health, CVS Health Ventures, RA Capital Management, Nexus NeuroTech Ventures, Google Ventures, Optum Ventures and Rock Health Capital. In total, Synapticure has raised $40 million.
Why Your Patients Are Leaving and How to Stop It
Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.
“Synapticure’s mission to provide accessible, high-quality care for neurodegenerative diseases aligns closely with our focus on investing in transformative healthcare companies led by visionary founders,” said Adam Seabrook, partner at B Capital, in a statement. “With the investor group’s combined expertise and resources, we believe this collaboration will continue to drive advancements in the treatment and care of patients living with Alzheimer’s and related dementias, Parkinson’s, and beyond.”
Synapticure is using the funding to grow its services and broaden partnerships with health systems, payers, and providers, including becoming a CMS GUIDE provider nationwide for those with Alzheimer’s. The company will also enhance its offerings by advancing AI-powered diagnostics, remote monitoring and 24/7 support. It will also connect more patients to emerging treatments and trials.
The funding comes as neurodegenerative diseases are on the rise with the population growing older. In the U.S., about 6.2 million people have Alzheimer’s disease, and nearly a million people have Parkinson’s disease. At the same time, there is an increasing shortage of neurologists to care for this population, and patients often have to wait six to nine months or longer for a neurology appointment.
“This surge is creating a burden on an increasing number of families and caregivers, who are often left navigating complex care systems with limited resources,” said Sandra Abrevaya, co-founder and CEO of Synapticure, in an email. “Caregivers frequently find themselves acting as care coordinators, advocates, and medical decision-makers while shouldering the emotional and physical weight of watching their loved one suffer. At the same time, specialized neurology care cannot keep pace with the rising demand. … Synapticure was created to address these challenges by providing fast access to expert care through a virtual model.”
How PDPM Optimization Improves Facility Financial Performance
Transitioning to PDPM models significantly shifted the healthcare industry. By replacing the RUG system, healthcare providers cut waste and more accurately reflect the care each patient received.
Long-term, the company aims to “redefine how neurodegenerative diseases are managed, ensuring that each patient and caregiver feels supported at every step of the journey,” Abrevaya added.
Other virtual companies providing care for conditions like Alzheimer’s and Parkinson’s include Harmonic Health and Isaac Health.
Photo: StockFinland, Getty Images